Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
暂无分享,去创建一个
M. Hewicker-Trautwein | H. Murua Escobar | I. Nolte | C. Junghanss | D. Koczan | M. Beller | X-F Wu | F. Weiner | J. T. Schille